AIHTA - Publications - Search - Entrectinib (Rozlytrek®) as monotherapy for the treatment of solid tumours with a NTRK gene fusion

Rothschedl, E. and Grössmann, N. (2024): Entrectinib (Rozlytrek®) as monotherapy for the treatment of solid tumours with a NTRK gene fusion. Fact Sheet Nr. 175.

[thumbnail of Fact Sheet Nr.175.pdf]
Preview
 PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
143kB

Item Type:Horizon Scanning of Medicines
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 50 Medical genetics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
Language:English
Series Name:Fact Sheet Nr. 175
Deposited on:12 Jun 2024 17:09
Last Modified:12 Jun 2024 17:09

Repository Staff Only: item control page